This compound is a deuterated pharmaceutical reference standard, specifically a labeled form of acemetacin impurity. It is a complex, ring-containing molecule with acidic and ester functional groups, used in analytical and pharmaceutical research for quality control and impurity profiling.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1196151-16-2
Carboxymethyl acemetacin
pharmaceutical intermediate
Diclofenac epolamine
pharmaceutical raw material
Benzamide, 3-(5-((1R,2S)-2-((2,2-difluoro-1-oxopropyl)amino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((3R)-tetrahydro-3-furanyl)-
pharmaceutical raw material
Sapitinib difumurate
pharmaceutical raw material
Cis-tranexamic acid
pharmaceutical raw material
Acemetacin
pharmaceutical raw material
2-tert-Butoxy-2-oxoethyl [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate
pharmaceutical intermediate
Indomethacin
pharmaceutical raw material
2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid
FSQKKOOTNAMONP-LNFUJOGGSA-N
[2H]C1=C(C(=C(C(=C1C(=O)N2C(=C(C3=C2C=CC(=C3)OC)CC(=O)OCC(=O)O)C)[2H])[2H])Cl)[2H]
—